Recent Advances in Vascularized Tumor-on-a-chip
Overview
Authors
Affiliations
The vasculature plays a critical role in cancer progression and metastasis, representing a pivotal aspect in the creation of cancer models. In recent years, the emergence of organ-on-a-chip technology has proven to be a robust tool, capable of replicating conditions with exceptional spatiotemporal resolution, making it a significant asset in cancer research. This review delves into the latest developments in 3D microfluidic vascularized tumor models and their applications , focusing on heterotypic cellular interactions, the mechanisms of metastasis, and therapeutic screening. Additionally, the review examines the benefits and drawbacks of these models, as well as the future prospects for their advancement.
Microfluidic model of the alternative vasculature in neuroblastoma.
Villasante A, Lopez-Martinez M, Quinonero G, Garcia-Lizarribar A, Peng X, Samitier J In Vitro Model. 2025; 3(1):49-63.
PMID: 39872066 PMC: 11756480. DOI: 10.1007/s44164-023-00064-x.
Munoz J, Pileggi G, Penteado Nucci M, Alves A, Pedrini F, Valle N Pharmaceutics. 2024; 16(9).
PMID: 39339193 PMC: 11434665. DOI: 10.3390/pharmaceutics16091156.
Microphysiological systems as models for immunologically 'cold' tumors.
Gaebler D, Hachey S, Hughes C Front Cell Dev Biol. 2024; 12:1389012.
PMID: 38711620 PMC: 11070549. DOI: 10.3389/fcell.2024.1389012.
Vascularized tumor models for the evaluation of drug delivery systems: a paradigm shift.
Lopez-Vince E, Wilhelm C, Simon-Yarza T Drug Deliv Transl Res. 2024; 14(8):2216-2241.
PMID: 38619704 PMC: 11208221. DOI: 10.1007/s13346-024-01580-3.